"CBD heralds a small revolution in the beauty and wellness fields. However, its development is not without a certain amount of confusion. How pure are the products on offer? What is the actual dosage? How do they comply with current regulations? Optimaceuticals was born of a militant desire to offer phytocannabinoid solutions whose quality criteria are set out in complete transparency, says Spectrums Europe. Optimaceuticals solutions are distinguished first and foremost by their purity: the highest concentrations of active ingredients, an absence of THC measured to 2 decimal places (0.00 %) and an absence of impurities guaranteed at 10 control points".
The natural origin of CBD guarantees its isomeric purity and therefore optimal efficacy. Obtained from industrial hemp grown organically in the USA, Optimaceuticals active ingredients are Cosmos, Natrue and Vegan Society certified.
Market-ready solutions
"To ensure the greatest operability of our ingredients, the Optimaceuticals range has been carefully thought through by application. The XB grades of the Optimaceuticals beauty line have undergone in vitro and in vivo evaluations to support your product claims. The XN grades of the Optimaceuticals nutrition line have been the subject of Novel Food dossiers submitted in January 2021 and declared valid by the European authorities in February 2022. "says the company.
Three first references launched at in-cosmetics 2022
- Optima CBD
The range's flagship product, Optima CBD is over 99% pure cannabidiol %. Its efficacy has been in vitro and in vivo with results on sebum regulation, modulation of inflammatory response, soothing properties tested on skin and scalp, and bacteriostatic activity.
- Optima CBG
Less well known to the general public, CBG (cannabigerol) is the precursor of all phytocannabinoids. An initial series of in vitro tests showed its remarkable activity in controlling sebum and modulating inflammatory response.
- Optima Broad Extract
Offering a CBD concentration of over 85 %, it also contains other phytocannabinoids of interest such as CBG (cannabigerol), CBE (cannabielsion) or CBC (cannabichromene), and a fine terpene profile.
These two references are the subject of novel food dossiers submitted in January 2021 and declared valid by the European authorities in February 2022. EFSA's opinion is awaited in
